Charity Excel Okechukwu
Registered Nurse · Yonkers, NYNPI 1417490707
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Novo Nordisk at 35.5% of the total. Among registered nurse clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $30.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$264
- Boston Scientific$174
- Boehringer Ingelheim$98
- Lilly USA, LLC$58
- Exact Sciences$45
- AstraZeneca$25
- plus $79 from 4 others
What the payments were for
- Food & beverage$72197%
- Education$223%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 3 | $264 |
| Boston Scientific | 10 | $174 |
| Boehringer Ingelheim | 1 | $98 |
| Lilly USA, LLC | 3 | $58 |
| Exact Sciences | 2 | $45 |
| AstraZeneca | 1 | $25 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
| Amgen | 1 | $20 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$250
How this compares
$743 in reported general payments places this provider in the 90th percentile of 446 registered nurse providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $347 |
| Omeprazole | 14 | $201 |
| Losartan Potassium | 15 | $158 |
| Metformin Hcl | 13 | $155 |
| Atorvastatin Calcium | 12 | $108 |
| Amlodipine Besylate | 21 | $103 |
| Lisinopril | 11 | $84 |
| Gabapentin | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other registered nurse in Yonkers
- Jane SeleyNew York$20K
- Chia-Wei LinBronx$15K
- Cathleen VarleyNew York$13K
- Hyojin KangOakland Gardens$7K
- Barbara RysWarwick$7K
- Janet KelskeWest Bay Shore$6K
- Kathleen Foley RootSmithtown$5K
- Lisa Desjardins-RitchieGreat Neck$4K
- Hilary NierenbergNew York$4K
- Sharon JasekSyracuse$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.